Carbamazepine-induced bullous fixed drug eruption: A case report - 22/08/24
Doi : 10.1016/j.therap.2023.09.002
Amal Habchane a, ⁎ 
, Fadwa Bentabet b, Soukaina Khatem a, Ayyoub Alioua a, c, Imane Adali b, Fatiha Manoudi b, Sanaa Zaoui a, d
, Fadwa Bentabet b, Soukaina Khatem a, Ayyoub Alioua a, c, Imane Adali b, Fatiha Manoudi b, Sanaa Zaoui a, d a Department of Pharmacology and Toxicology, Clinical Research Center, Mohammed VI University Hospital, 4000 Marrakesh, Morocco
b Department of Psychiatry, Ibn Nafis Hospital, Mohamed VI University Hospital, 4000 Marrakech, Morocco
c Faculty of Medicine and Pharmacy, Science and Technology and Medical Sciences, Bioscience, and Health Laboratory, Cadi Ayyad University, 4000 Marrakech, Morocco
d Faculty of Medicine and Pharmacy, Bioscience and Health Laboratory, Cadi Ayyad University, 4000 Marrakesh, Morocco
⁎Corresponding author.
Keywords : Carbamazepine-induced, Fixed drug eruption, Bullous, Case report
Le texte complet de cet article est disponible en PDF.
Plan
| ☆ | This case has been declared to the Anti-Poison and Pharmacovigilance Center of Marrakesh (Morocco) on 28th February 2023 under the number MA-CAPM-300071228. |
© 2023
Société française de pharmacologie et de thérapeutique. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 4
P. 477-479 - juillet 2024 Retour au numéro
Article précédent
- Pharmacokinetic drug-drug interactions between Paxlovid® (nirmatrelvir/ritonavir) and CFTR modulators for cystic fibrosis
- Tessa Pietri, Delphine Laugier, Frank Rouby, Joëlle Micallef
- Isolated conjugated hyperbilirubinemia with rifampicin and cross-reaction with rifabutin: A drug-endogenous substance interaction case report
- Samuel D. Cohen, Charlotte Devant, Laure Delaval, Caroline Charlier, Etienne Canouï, Laurent Chouchana
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?